Asta
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Asta makes mass spectrometry instruments, analytical devices that identify unknown substances by measuring the mass of molecules, for both medical and industrial use, and supplies them to hospitals, clinics, and manufacturers in display, battery, and semiconductor industries.
Its medical instruments help laboratories identify bacteria and fungi from patient samples, while its industrial instruments are used for quality-control inspection on factory production lines. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company has expanded its product portfolio from medical microbiology diagnostics into industrial process analysis, with distinct instrument lines targeting display, electric-vehicle battery, and semiconductor applications.
Summary is AI-generated and may contain errors · figures from DART filings
Asta in five facts
What does Asta do?
Asta makes mass spectrometry instruments, analytical devices that identify unknown substances by measuring the mass of molecules, for both medical and industrial use, and supplies them to hospitals, clinics, and manufacturers in display, battery, and semiconductor industries.
Where is Asta listed and in which sector?
Asta (Korean name: 아스타) trades under KRX code 246720 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is Asta?
Its market capitalisation was US$75M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Asta's latest annual revenue and operating profit?
For fiscal year 2025, Asta reported revenue of US$2M, an operating loss of US$2M and a net loss of US$2.5M, per its annual report on DART (data retrieved from DART on 2026-09-18). Revenue was down 22.6% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-18
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- DisclosureOct 21
- Report on large shareholdings (5% rule) (standard)Oct 20
- Share transfer agreement tied to the largest shareholder terminated/cancelled
Asta's controlling stake is set to change hands from an individual and 1 other to SD Biosensor, in a deal worth US$24.4M.
Ownership change · Oct 16 - [Amended] Report on large shareholdings (5% rule) (standard)Oct 8
- Report on large shareholdings (5% rule) (standard)Oct 8
- Supply contract signed
Asta disclosed a supply contract with DIATECH TECHNOLOGY CO.,LTD., worth US$761K, about 30.37% of its recent annual revenue, running through Jan 2027.
Supply contract · Oct 6 - [Amended] Share-pledge agreement that may change the largest shareholder
Asta's largest shareholder pledged shares as loan collateral, securing up to US$17.8M.
Ownership change · Sep 30 - [Amended] Share transfer agreement that will change the largest shareholder
Asta's controlling stake is now set to change hands from an individual and 1 other to SD Biosensor, in a deal worth US$24.2M.
Ownership change · Sep 30 · 5 versions - [Amended] Share-pledge agreement that may change the largest shareholder
Asta's largest shareholder pledged shares as loan collateral, securing up to US$15.7M.
Ownership change · Jun 23 - Supply contract signed
Asta disclosed a supply contract with Kangwon National University, worth US$271K, about 11.95% of its recent annual revenue, running through Aug 2026.
Supply contract · Apr 22 - [Amended] Share-pledge agreement that may change the largest shareholder
Asta's largest shareholder pledged shares as loan collateral, securing up to US$15.9M.
Ownership change · Mar 30 - [Amended] Share-pledge agreement that may change the largest shareholder
Asta's largest shareholder pledged shares as loan collateral, securing up to US$16M.
Ownership change · Mar 27 - Supply contract signed
Asta disclosed a supply contract with Chungnam National University, worth US$293K, about 13.14% of its recent annual revenue, running through Aug 2026.
Supply contract · Mar 23 - Material event report (decision to redeem own convertible bonds early)Capital raise · Mar 20
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Asta reported separate results for FY2025: revenue of US$2.11M (−9.5% year on year), an operating loss of US$1.77M and a net loss of US$2.34M.
Earnings · Feb 25 - Securities issuance results (voluntary) (third-party placement)Capital raise · Feb 24
- [Amended] Share-pledge agreement that may change the largest shareholder
Asta's largest shareholder pledged shares as loan collateral, securing up to US$16.5M.
Ownership change · Feb 10 - Material event report (rights offering)
Asta disclosed a private placement (third-party allotment) to raise US$7.17M, about 10.5% of its market value.
Capital raise · Feb 10